Pharmaceutical Intermediate Market by Type (GMP, and Non GMP), Application (Antibiotics, Antipyretic, Analgesics, Vitamins, and Others), and by Region, Global Trends and Forecast from 2019 to 2026

Published on: Mar 2022
From:USD $3499.00
Number Of Pages:120

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
73 billion by 2026	7.3%	North America

by Type	by Application	by Regions
GMP Non GMP	Antibiotic Antipyeritic Analgesics Vitamins Other	North America Europe Asia Pacific South America Middle East And Africa

4.9/5 - (20 votes)

Pharmaceutical Intermediate Market Overview

The Global Pharmaceutical Intermediates Market is expected to grow at more than 7.3% CAGR from 2021 to 2026. It is expected to reach above USD 73 billion by 2026 from a little above USD 48 billion in 2020.

Pharmaceutical intermediates serve as fundamental materials in the production of bulk drugs. Prominent biopharmaceutical and pharmaceutical manufacturing entities are strategically directing their efforts towards enhancing their global market presence. This strategic focus entails bolstering product distribution networks across diverse regions worldwide. Consequently, the growth trajectory for the pharmaceutical intermediates market remains optimistic, as industry players persistently endeavor to augment production capacities across various global locations.

pharmaceutical intermediates | Exactitude Consultancy

Anticipated market development is attributable to the escalating prevalence of respiratory ailments such as lung cancer and chronic obstructive pulmonary diseases. Notably, the World Health Organization (WHO) underscored in its January 2022 report that Chronic Obstructive Pulmonary Disease (COPD) ranks as the third most prevalent cause of global morbidity and mortality. A substantial proportion of this burden emanates from low- and middle-income nations (LMICs), thereby driving the imperative for efficacious disease management, which in turn is poised to propel market expansion.

Intermediates, defined as semi-finished products intermediate to certain end products, offer a cost-effective means of production. In essence, these intermediates serve as precursors to final products, facilitating cost efficiencies. The pharmaceutical sector requires an array of specialized chemicals, historically produced within the pharmaceutical industry. However, advancements in production technology and the evolution of labor division have enabled the pharmaceutical industry to outsource the production of requisite intermediates to chemical enterprises. Pharmaceutical intermediates constitute intricate chemical formulations, with production witnessing significant growth within the global chemical industry. The burgeoning chemical sector acts as a catalyst for the heightened demand for pharmaceutical intermediates worldwide, with production tailored to accommodate bulk and customized requirements.

pharmaceutical intermediates | Exactitude Consultanc

Pharmaceutical Intermediate Market Segment Analysis

On the basis of Type, Pharmaceutical Intermediates is segmented in terms of GMP and Non GMP. GMP products are manufactured in the controlled atmosphere according to quality standards prescribed b according to quality standards prescribed by the international institutions. Major risks include unexpected product expectation which can result in adverse health condition and not following guidelines for packaging. Whereas Non GMP practices are adopted for pre-clinical and toxicological studies in order to assess the technical feasibility and formulation and further scale up to clinical and commercial manufacturing

On the basis of application, the global Pharmaceutical Intermediates market is segmented into antibiotic, vitamins, antipyretic analgesics, and others. Antibiotics are used to fight bacterial infections and variety of antibiotics are available depending on their range of applications. The market for antipyretic analgesics is growing with increase in geriatric population who is suffering from arthritis, toothache and other disorders. Similarly, vitamins demand also increasing with rising awareness of healthy dietary practices. Other application of pharmaceutical intermediates includes in cardiovascular drugs, oncology drugs, neurological drugs etc.

Pharmaceutical Intermediate Market Players

Major providers of the pharmaceutical intermediate’s player are concentrated in Asia and majorly in China and India. The market players are increasing their market share by undergoing innovative practices, increasing the sustainable component of production process and using it to attract investors. Market players are also employing strategy for mergers and acquisition and using the synergy created through it to increase the product portfolio and regional presence. Few of the important market players include Lonza, Catalent, Patheon N.V, Jubilant Ingrevia, Ganesh Chemical, Chemcon, BASF, Lianhetech, ABA Chem, Porton, Jiansu Jiu Technology, and Tianma among others

With development of genetic technology there is immense scope for the growth of personalized medicine. Personalized medicine, also referred to as precision medicine, is a medical model that separates people into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease. This trend is likely to create renewed interest in research and development of new drugs which will the propel the growth for pharmaceutical intermediates market.

Who Should Buy? Or Key Stakeholders

Medical Technology Companies
Drug Manufacturers
Environment, Health and Safety Professionals
Vaccine Manufacturers
Research Organizations
Medical Devices manufacturers
Regulatory Authorities
Others

Pharmaceutical Intermediate Market Regional Analysis

Geographically, the global Pharmaceutical Intermediates market is segmented into North America, South America, Europe, APAC and MEA.

North America: includes the US, Canada, Mexico
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

pharmaceutical intermediates | Exactitude Consultancy

In 2020, North America held the largest market share in the global Pharmaceutical Intermediates market and is projected to grow at a steady pace during the forecast period. The major demand of the Pharmaceutical Intermediates is generated from the North American region, especially from the US. This is attributed to presence of big pharmaceutical companies which has huge foot print in global pharmaceutical market. These major players are involved in the research and development of new drugs to meet the future requirement as well as to combat to the problems whose solutions are yet to be identified. Further, higher prevalence of chronic diseases has been vital for increasing the demand of pharmaceutical drugs in the North America market.

Key Market Segments: Pharmaceutical Intermediates Market

Pharmaceutical Intermediates Market by Type, 2019-2026, (In USD Million)

Gmp
Non Gmp

Pharmaceutical Intermediates Market by Applications, 2019-2026, (In USD Million)

Antibiotic
Antipyeritic Analgesics
Vitamins
Other

Pharmaceutical Intermediates Market Regions, 2019-2026, (In USD Million)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important countries in all regions are covered

Key Question Answered

What is the current market size of this high growth market?
What is the overall growth rate?
What are the key growth areas, applications and types?
Key reasons for growth
Challenges for growth
Who are the important market players in this market?
What are the key strategies of these players?
What technological developments are happening in this area?

1. SCOPE OF THE REPORT
  1. MARKET INTRODUCTION
  2. YEARS CONSIDERED
  3. MARKET SEGMENTATION
  4. RESEARCH OBJECTIVES
  5. MARKET RESEARCH METHODOLOGY
    1. DATA MINING
      1. SECONDARY RESEARCH
      2. PRIMARY RESEARCH
    2. SUBJECT-MATTER EXPERTS’ ADVICE
    3. QUALITY CHECKS
      1. FINAL REVIEW
    4. DATA TRIANGULATION
    5. RESEARCH FLOW
  6. DATA SOURCES
  7. CURRENCY CONSIDERED
2. EXECUTIVE SUMMARY
  1. WORLD MARKET OVERVIEW
    1. GLOBAL PHARMACEUTICAL INTERMEDIATES 2016-2026
  2. PHARMACEUTICAL INTERMEDIATES SEGMENT BY TYPE
    1. GMP
    2. NON-GMP
    3. GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE (2016-2026)
  3. PHARMACEUTICAL INTERMEDIATES SEGMENT BY APPLICATION
    1. ANTIBIOTICS
    2. ANTIPYRETIC ANALGESICS
    3. VITAMINS
    4. OTHERS
    5. GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION (2016-2026)
1. GLOBAL PHARMACEUTICAL INTERMEDIATES BY COMPANY
  1. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SHARE BY COMPANY
  2. KEY MANUFACTURERS PHARMACEUTICAL INTERMEDIATES PRODUCING AREA DISTRIBUTION, SALES AREA
  3. MARKET CONCENTRATION RATE ANALYSIS
    1. COMPETITION LANDSCAPE ANALYSIS
1. PHARMACEUTICAL INTERMEDIATES BY REGION
  1. PHARMACEUTICAL INTERMEDIATES BY REGION
    1. GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY REGION
    2. GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE
    3. GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION
  2. NORTH AMERICA PHARMACEUTICAL INTERMEDIATES GROWTH
  3. EUROPE PHARMACEUTICAL INTERMEDIATES GROWTH
  4. APAC PHARMACEUTICAL INTERMEDIATES GROWTH
  5. MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES GROWTH
  6. SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES GROWTH
2. NORTH AMERICA
  1. NORTH AMERICA
    1. NORTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY COUNTRY (2016-2020)
  2. NORTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
  3. NORTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    1. UNITED STATES
      1. US PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. US PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    2. CANADA
      1. CANADA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. CANADA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    3. MEXICO
      1. MEXICO PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. MEXICO PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
1. ASIA PACIFIC
  1. ASIA-PACIFIC
    1. APAC PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY COUNTRY (2016-2020)
    2. APAC PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
    3. APAC PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    4. CHINA
      1. CHINA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. CHINA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    5. JAPAN
      1. JAPAN PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. JAPAN PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    6. INDIA
      1. INDIA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. INDIA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    7. SOUTH KOREA
      1. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    8. ASEAN
      1. ASEAN PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. ASEAN PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    9. AUSTRALIA
      1. AUSTRALIA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. AUSTRALIA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    10. REST OF APAC
      1. REST OF APAC PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. REST OF APAC PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
1. EUROPE
  1. EUROPE
    1. EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY COUNTRY (2016-2020)
    2. EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
    3. EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    4. GERMANY
      1. GERMANY PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. GERMANY PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    5. UK
      1. UK PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. UK PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    6. FRANCE
      1. FRANCE PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. FRANCE PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    7. ITALY
      1. ITALY PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. ITALY PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    8. RUSSIA
      1. RUSSIA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. RUSSIA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    9. SPAIN
      1. SPAIN PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. SPAIN PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    10. REST OF EUROPE
      1. REST OF EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. REST OF EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
1. MIDDLE EAST & AFRICA
  1. MIDDLE EAST & AFRICA
    1. MEA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY COUNTRY (2016-2020)
    2. MEA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
    3. MEA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    4. TURKEY
      1. TURKEY PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. TURKEY PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    5. UAE
      1. UAE PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. UAE PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    6. SAUDI ARABIA
      1. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    7. SOUTH AFRICA
      1. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    8. REST OF MEA
      1. REST OF MEA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. REST OF MEA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
1. SOUTH AMERICA
  1. SOUTH AMERICA
    1. SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY COUNTRY (2016-2020)
    2. SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
    3. SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    4. BRAZIL
      1. BRAZIL PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. BRAZIL PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    5. ARGENTINA
      1. ARGENTINA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. ARGENTINA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
    6. REST OF SOUTH AMERICA
      1. REST OF SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
      2. REST OF SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION
1. MARKET DRIVERS, CHALLENGES AND TRENDS
  1. MARKET DRIVERS AND IMPACT
    1. GROWING CHRONIC DISEASE PREVALENCE COUPLED WITH GROWTH IN INFECTIOUS DISEASES
    2. INCREASING R&D INVESTMENTS FOR DRUG MANUFACTURING
  2. MARKET CHALLENGES AND IMPACT
    1. HIGH MANUFACTURING COSTS GIVING EARLY MOVERS HUGE ADVANTAGE
  3. MARKET TRENDS
    1. ADVANCEMENTS IN AUTOMATION AND ITS APPLICATION IN DRUG DISCOVERY, MANUFACTURING AND TESTING
1. MARKETING, DISTRIBUTORS AND CUSTOMER
  1. SALES CHANNEL
    1. DIRECT CHANNELS
    2. INDIRECT CHANNELS
1. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET FORECAST
  1. GLOBAL PHARMACEUTICAL INTERMEDIATES FORECAST (2021-2026)
    1. NORTH AMERICA CONSUMPTION FORECAST
      1. NORTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
    2. APAC CONSUMPTION FORECAST
      1. APAC PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
    3. EUROPE CONSUMPTION FORECAST
      1. EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
    4. MIDDLE EAST & AFRICA CONSUMPTION FORECAST
      1. MEA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
    5. SOUTH AMERICA CONSUMPTION FORECAST
      1. SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE
    6. NORTH AMERICA FORECAST BY COUNTRY
      1. UNITED STATES MARKET FORECAST
      2. CANADA MARKET FORECAST
      3. MEXICO MARKET FORECAST
    7. EUROPE
      1. GERMANY MARKET FORECAST
      2. UK MARKET FORECAST
      3. FRANCE MARKET FORECAST
      4. ITALY MARKET FORECAST
      5. RUSSIA MARKET FORECAST
      6. SPAIN MARKET FORECAST
      7. REST OF EUROPE MARKET FORECAST
    8. ASIA-PACIFIC
      1. CHINA MARKET FORECAST
      2. JAPAN MARKET FORECAST
      3. INDIA MARKET FORECAST
      4. AUSTRALIA MARKET FORECAST
      5. SOUTH KOREA MARKET FORECAST
      6. ASEAN MARKET FORECAST
      7. REST OF APAC MARKET FORECAST
    9. MEA
      1. TURKEY MARKET FORECAST
      2. UAE MARKET FORECAST
      3. SAUDI ARABIA MARKET FORECAST
      4. SOUTH AFRICA MARKET FORECAST
      5. REST OF MEA MARKET FORECAST
    10. SOUTH AMERICA
      1. BRAZIL MARKET FORECAST
      2. ARGENTINA MARKET FORECAST
      3. REST OF SA MARKET FORECAST
1. KEY PLAYERS ANALYSIS
  1. LONZA
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. LONZA PHARMACEUTICAL INTERMEDIATES SALES, REVENUE,AND GROSS MARGIN (2017-2019)
    4. MAIN BUSINESS OVERVIEW
    5. LONZA NEWS
  2. CATALENT
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. CATALENT PHARMACEUTICAL INTERMEDIATES SALES, REVENUE, AND GROSS MARGIN (2017-2019)
    4. MAIN BUSINESS OVERVIEW
    5. CATALENT NEWS
  3. PATHEON N.V
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. MAIN BUSINESS OVERVIEW
    4. PATHEON NEWS
  4. JUBILANT INGREVIA
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. MAIN BUSINESS OVERVIEW
    4. JUBILANT INGREVIA NEWS
  5. GRANULES
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. GRANULES PHARMACEUTICAL INTERMEDIATES SALES, REVENUE, AND GROSS MARGIN 2017-2019)
    4. MAIN BUSINESS OVERVIEW
    5. GRANULES NEWS
  6. GANESH
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. MAIN BUSINESS OVERVIEW
    4. GANESH PHARMACEUTICAL INTERMEDIATES SALES, REVENUE, AND GROSS MARGIN (2017-2019)
  7. CHEMCON
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. CHEMCON PHARMACEUTICAL INTERMEDIATES SALES, REVENUE, AND GROSS MARGIN (2017-2019)
    4. MAIN BUSINESS OVERVIEW
    5. CHEMCON NEWS
  8. BASF
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. BASF PHARMACEUTICAL INTERMEDIATES SALES, REVENUE, PRICE AND GROSS MARGIN (2017-2019)
    4. MAIN BUSINESS OVERVIEW
    5. BASF NEWS
  9. LIANHETECH
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. LIANHETECH PHARMACEUTICAL INTERMEDIATES SALES, REVENUE, PRICE AND GROSS MARGIN (2017-2019)
    4. MAIN BUSINESS OVERVIEW
    5. LIANHETECH NEWS
  10. ABA CHEM
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. MAIN BUSINESS OVERVIEW
    4. ABA CHEM NEWS
  11. PORTON
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. PORTON PHARMACEUTICAL INTERMEDIATES SALES, REVENUE, PRICE AND GROSS MARGIN (2017-2019)
    4. MAIN BUSINESS OVERVIEW
    5. PORTON NEWS
  12. JIANGSU JIUJIUJIU TECHNOLOGY CO., LTD
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. MAIN BUSINESS OVERVIEW
  13. ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD.
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. MAIN BUSINESS OVERVIEW
    4. ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD.NEWS
  14. TIANMA
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. MAIN BUSINESS OVERVIEW
  15. ALPHA
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. MAIN BUSINESS OVERVIEW
  16. YONGTAI
    1. COMAPANY DETAILS
    2. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED
    3. MAIN BUSINESS OVERVIEW
LIST OF TABLES

TABLE 1              GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE BY TYPE, 2019-2026, (USD BILLION)

TABLE 2              GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE BY APPLICATION, 2019-2026, (USD BILLION)

TABLE 3              KEY MANUFACTURERS PHARMACEUTICAL INTERMEDIATES

TABLE 4              KEY MANUFACTURERS PHARMACEUTICAL INTERMEDIATES

TABLE 5              GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY REGION, 2016-2026, IN USD MILLION

TABLE 6              GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE, 2016-2026, IN USD MILLION

TABLE 7               GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION, 2016-2026, IN USD MILLION

TABLE 8              NORTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY COUNTRY (2016-2020)

TABLE 9              NORTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 10            NORTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 11            US PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 12            US PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 13            CANADA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 14            CANADA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 15            MEXICO PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 16            MEXICO PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 17            APAC PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY COUNTRY (2016-2020)

TABLE 18            APAC PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 19            APAC PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 20           CHINA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 21            CHINA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 22           JAPAN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 23            JAPAN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 24           INDIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 25            INDIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 26           SOUTH KOREA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 27            SOUTH KOREA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 28           ASEAN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 29           ASEAN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 30            AUSTRALIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 31            AUSTRALIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 32            REST OF APAC PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 33            REST OF APAC PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 34            EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY COUNTRY (2016-2020)

TABLE 35            EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 36            EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 37            GERMANY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 38            GERMANY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 39            UK PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 40           UK PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 41            FRANCE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 42           FRANCE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 43            ITALY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 44           ITALY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 45            RUSSIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 46           RUSSIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 47            SPAIN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 48           SPAIN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 49           REST OF EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 50            REST OF EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 51            MEA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY COUNTRY (2016-2020)

TABLE 52            MEA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 53            MEA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 54            TURKEY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 55            TURKEY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 56            UAE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 57            UAE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 58            SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 59            SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 60           SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 61            SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 62           REST OF MEA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 63            REST OF MEA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 64           SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY COUNTRY (2016-2020)

TABLE 65            SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 66           SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 67            BRAZIL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 68           BRAZIL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 69           ARGENTINA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 70            ARGENTINA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 71            REST OF SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2016-2020)

TABLE 72            REST OF SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY APPLICATION (2016-2020)

TABLE 73            GLOBAL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST (2019-2026)

TABLE 74            NORTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 75            APAC PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 76            EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 77             MEA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 78            SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 79            US PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 80           US PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 81            CANADA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 82           CANADA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 83            MEXICO PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 84           MEXICO PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 85            GERMANY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 86           GERMANY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 87            UK PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 88           UK PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 89           FRANCE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 90           FRANCE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 91            ITALY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 92           ITALY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 93            RUSSIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 94           RUSSIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 95            SPAIN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 96           SPAIN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 97            REST OF EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 98           REST OF EUROPE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 99           CHINA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 100         CHINA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 101         JAPAN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 102         JAPAN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 103         INDIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 104         INDIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 105         AUSTRALIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 106         AUSTRALIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 107          SOUTH KOREA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 108         SOUTH KOREA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 109         ASEAN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 110         ASEAN PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 111          REST OF APAC PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 112         REST OF APAC PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 113          TURKEY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 114         TURKEY PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 115          UAE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 116         UAE PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 117          SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 118         SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 119         SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 120         SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 121         REST OF MEA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 122         REST OF MEA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 123         BRAZIL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 124         BRAZIL PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 125         ARGENTINA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 126         ARGENTINA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 127          REST OF SA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) BY TYPE (2019-2026)

TABLE 128         REST OF SA PHARMACEUTICAL INTERMEDIATES REVENUE (USD MILLION) FORECAST BY APPLICATION (2019-2026)

TABLE 129         LONZA BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 130         LONZA PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 131          LONZA MAIN BUSINESS

TABLE 132         LONZA RECENT DEVELOPMENT

TABLE 133          CATALENT BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 134         CATALENT PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 135          CATALENT MAIN BUSINESS

TABLE 136         CATALENT RECENT DEVELOPMENT

TABLE 137          PATHEON BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 138         PATHEON PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 139         PATHEON MAIN BUSINESS

TABLE 140         PATHEON RECENT DEVELOPMENT

TABLE 141         JUBILANT INGREVIA BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 142         JUBILANT INGREVIA PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 143         JUBILANT INGREVIA MAIN BUSINESS

TABLE 144         JUBILANT INGREVIA RECENT DEVELOPMENT

TABLE 145         GRANULES BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 146         GRANULES PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 147          GRANULES MAIN BUSINESS

TABLE 148         GRANULES RECENT DEVELOPMENT

TABLE 149         GANESH BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 150         GANESH PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 151          GANESH MAIN BUSINESS

TABLE 152         CHEMCON BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 153          CHEMCON PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 154         CHEMCON MAIN BUSINESS

TABLE 155          CHEMCON RECENT DEVELOPMENT

TABLE 156         BASF BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 157          BASF PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 158         BASF MAIN BUSINESS

TABLE 159         BASF RECENT DEVELOPMENT

TABLE 160         LIANHETECH BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 161         LIANHETECH PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 162         LIANHETECH MAIN BUSINESS

TABLE 163         LIANHETECH RECENT DEVELOPMENT

TABLE 164         ABA CHEM BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 165         ABA CHEM PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 166         ABA CHEM MAIN BUSINESS

TABLE 167          ABA CHEM RECENT DEVELOPMENT

TABLE 168         PORTON BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 169         PORTON PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 170          PORTON MAIN BUSINESS

TABLE 171          PORTON RECENT DEVELOPMENT

TABLE 172          JIANGSU JIUJIUJIU TECHNOLOGY CO., LTD BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 173          JIANGSU JIUJIUJIU TECHNOLOGY CO., LTD PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 174          JIANGSU JIUJIUJIU TECHNOLOGY CO., LTD MAIN BUSINESS

TABLE 175          ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 176          ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 177          ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. MAIN BUSINESS

TABLE 178          ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. RECENT DEVELOPMENT

TABLE 179          TIANMA BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 180         TIANMA PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 181         TIANMA MAIN BUSINESS

TABLE 182         ALPHA BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 183         ALPHA PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 184         ALPHA MAIN BUSINESS

TABLE 185         YONGTAI BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS

TABLE 186         YONGTAI PHARMACEUTICAL INTERMEDIATES PRODUCT OFFERED

TABLE 187          YONGTAI MAIN BUSINESS

LIST OF FIGURES

FIGURE 1            RESEARCH TIMELINES

FIGURE 2            MARKET SEGMENTATION

FIGURE 3            DATA TRIANGULATION

FIGURE 4            MARKET RESEARCH FLOW

FIGURE 5            DATA SOURCES

FIGURE 6            GLOBAL PHARMACEUTICAL INTERMEDIATES VALUE (USD MILLION), BY REGION 2016-2026

FIGURE 7             COMPETITION LANDSCPE BY REGION

FIGURE 8            NORTH AMERICA PHARMACEUTICAL INTERMEDIATES GROWTH, IN USD MILLION

FIGURE 9            EUROPE PHARMACEUTICAL INTERMEDIATES GROWTH IN USD MILLION

FIGURE 10          APAC PHARMACEUTICAL INTERMEDIATES GROWTH IN USD MILLION

FIGURE 11          MEA PHARMACEUTICAL INTERMEDIATES GROWTH IN USD MILLION

FIGURE 12          SOUTH AMERICA PHARMACEUTICAL INTERMEDIATES GROWTH IN USD MILLION

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT